Cargando…
Ebola and the need for restructuring pharmaceutical incentives
Autores principales: | Karan, Abraar, Pogge, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Edinburgh University Global Health Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337146/ https://www.ncbi.nlm.nih.gov/pubmed/25734003 http://dx.doi.org/10.7189/jogh.05.010303 |
Ejemplares similares
-
Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts
por: Kannarkat, Joseph T., et al.
Publicado: (2020) -
Ebola: A Hyperinflated Emergency
por: Barbiero, Victor K.
Publicado: (2020) -
Providing nursing care to Ebola virus disease patients: China Ebola Treatment Unit experience
por: Cao, Jie, et al.
Publicado: (2015) -
Good and Bad News about Ebola
por: Peterson, A. Townsend
Publicado: (2015) -
Ebola in children: a personal perspective
por: Shah, Tejshri
Publicado: (2015)